Cargando…

Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases

The human patatin-like phospholipase domain-containing 3 gene (PNPLA3) is highly expressed in liver and adipose tissue and encodes a transmembrane polypeptide chain containing 481 amino acids. The I148M variant of PNPLA3 is a single nucleotide polymorphism, which is related to a variety of liver and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Hongjiao, Wu, Zecheng, Wang, Junmin, Wu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408107/ https://www.ncbi.nlm.nih.gov/pubmed/34476007 http://dx.doi.org/10.7150/jca.57951

Ejemplares similares

PNPLA3 expression and its impact on the liver: current perspectives
por: Bruschi, Francesca Virginia, et al.
Publicado: (2017)

PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction
por: Gou, Yusong, et al.
Publicado: (2023)

The role of PNPLA3 (rs738409) c>g variant on histological progression of non-alcoholic fatty liver disease
por: Idilman, Ramazan, et al.
Publicado: (2020)

Genetic Variants in PNPLA3 and Risk of Non-Alcoholic Fatty Liver Disease in a Han Chinese Population
por: Peng, Xian-E, et al.
Publicado: (2012)

Association of PNPLA3 I148M Variant With Chronic Viral Hepatitis, Autoimmune Liver Diseases and Outcomes of Liver Transplantation
por: Geng, Ning, et al.
Publicado: (2015)

Qinggan Huoxue Recipe Alleviates Alcoholic Liver Injury by Suppressing Endoplasmic Reticulum Stress Through LXR-LPCAT3
por: Lu, Yifei, et al.
Publicado: (2022)

The Association of PNPLA3 Variants with Liver Enzymes in Childhood Obesity Is Driven by the Interaction with Abdominal Fat
por: Miraglia del Giudice, Emanuele, et al.
Publicado: (2011)

Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
por: Shao, Mingmei, et al.
Publicado: (2022)

Kaempferol Alleviates Steatosis and Inflammation During Early Non-Alcoholic Steatohepatitis Associated With Liver X Receptor α-Lysophosphatidylcholine Acyltransferase 3 Signaling Pathway
por: Xiang, Hongjiao, et al.
Publicado: (2021)

Research progress in the role and mechanism of Cadherin-11 in different diseases
por: Chen, Xinyi, et al.
Publicado: (2021)

A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease
por: Zain, Shamsul Mohd, et al.
Publicado: (2012)

Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans
por: Liu, Wanqing, et al.
Publicado: (2016)

The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation
por: BasuRay, Soumik, et al.
Publicado: (2017)

Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth
por: Monga Kravetz, Ayesha, et al.
Publicado: (2020)

PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center
por: Semmler, Georg, et al.
Publicado: (2021)

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
por: Romeo, Stefano, et al.
Publicado: (2008)

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
por: Lu, Yifei, et al.
Publicado: (2022)

Qinggan Huoxue Recipe attenuates Alcoholic Liver Disease by suppressing PI3K/AKT signaling pathway based on network pharmacology
por: Wang, Junmin, et al.
Publicado: (2023)

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients
por: Núñez-Torres, Rocío, et al.
Publicado: (2016)

PNPLA3 polymorphism increases risk for and severity of chronic hepatitis C liver disease
por: Salameh, Habeeb, et al.
Publicado: (2016)

PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease
por: Wang, Jin-Zhi, et al.
Publicado: (2018)

PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
por: Dong, Xiaocheng Charlie
Publicado: (2019)

Role and clinical significance of TGF-β1 and TGF-βR1 in malignant tumors (Review)
por: Wang, Junmin, et al.
Publicado: (2021)

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease
por: Hotta, Kikuko, et al.
Publicado: (2010)

Effects of PNPLA3 on Liver Fat and Metabolic Profile in Hispanic Children and Adolescents
por: Goran, Michael I., et al.
Publicado: (2010)

TGF-Β1, PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
por: Smagris, Eriks, et al.
Publicado: (2015)

Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M
por: Rausch, Vanessa, et al.
Publicado: (2016)

Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C
por: De Nicola, Stella, et al.
Publicado: (2014)

Gordon Holmes syndrome due to compound heterozygosity of two new PNPLA6 variants – A diagnostic challenge
por: Salgado, Paula, et al.
Publicado: (2018)

PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2013)

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease
por: Li, Gang, et al.
Publicado: (2022)

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
por: Lindén, Daniel, et al.
Publicado: (2019)

Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH
por: Bruschi, Francesca V., et al.
Publicado: (2020)

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection
por: Scheiner, Bernhard, et al.
Publicado: (2015)

Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women
por: Cherubini, Alessandro, et al.
Publicado: (2023)

No Correlation between PNPLA3 rs738409 Genotype and Fatty Liver and Hepatic Cirrhosis in Japanese Patients with HCV
por: Nakamura, Masato, et al.
Publicado: (2013)

The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population
por: Balasus, Daniele, et al.
Publicado: (2016)

Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease
por: Wu, Jian-Ting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i5j3q5kt900dmtrm7gjrq0sdiq